{"podcast":{"title":"Answers from the Lab","slug":"answers-from-the-lab-870296","podcast_index_feed_id":870296,"rss_url":"https://feeds.transistor.fm/answers-from-the-lab","website_url":"https://news.mayocliniclabs.com/podcast/answers-from-the-lab/","image_url":"https://img.transistorcdn.com/B9HbHcxSMFuy8GSjzQspBU_yr7OZ0kDg-c2slusbf14/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.jpg","author":"Mayo Clinic Laboratories","episode_count":383,"summary":"A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.","last_synced_at":"2026-06-11T16:18:30.710370+00:00","page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296"},"episode":{"title":"Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.","slug":"developments-for-ldt-regulation-and-laboratory-reimbursement-bill-morice-m-d-ph-d","published_at":"2025-10-16T07:00:00+00:00","page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296/developments-for-ldt-regulation-and-laboratory-reimbursement-bill-morice-m-d-ph-d","show_page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296","url":"https://share.transistor.fm/s/e9089f31","audio_url":"https://media.transistor.fm/e9089f31/563c0a27.mp3","summary":"Published October 16, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, discuss recent regulatory and policy developments. Together, they explore: FDA rescinds rule on LDTs (00:48): The FDA has officially withdrawn its rule that would allow oversight of laboratory-developed tests (LDTs) as medical devices. The conversation explores what this decision means and what might come next for LDT regulation. PAMA reform update and new RESULTS Act (05:13): The newly introduced Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act aims to address reimbursement for laboratory tests. Getting engaged (12:37): Why it is important to understand new regulatory policies and help others understand their implications for the industry. Resources Find past “Answers From the Lab” podcasts on LDTs and PAMA","meta_description":"Published October 16, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clini…","key_points":[],"chapters":[],"topics":[],"duration_seconds":952,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/answers-from-the-lab-870296/episodes/developments-for-ldt-regulation-and-laboratory-reimbursement-bill-morice-m-d-ph-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/answers-from-the-lab-870296/developments-for-ldt-regulation-and-laboratory-reimbursement-bill-morice-m-d-ph-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}